Design rationale and preclinical evaluation of the HeartMate 3 left ventricular assist system for hemocompatibility

ASAIO Journal

Volumn 62, Issue 4, 2016, Pages 375-383

  Bourque, Kevin ^a   Cotter, Christopher ^a   Dague, Charles ^a   Harjes, Daniel ^a   Dur, Onur ^a   Duhamel, Julien ^a   Spink, Kaitlyn ^a   Walsh, Kelly ^a   Burke, Edward ^a  

^a St Jude Medical Inc   (United States)

Author keywords

HeartMate 3; hemocompatibility; magnetic levitation; Preclinical testing

Indexed keywords

BLOOD; COMPUTATIONAL FLUID DYNAMICS; DESIGN; LEFT VENTRICULAR ASSIST DEVICES; OPTICAL PUMPING; PUMPS; SHEAR STRESS;

CENTRIFUGAL FLOW; CLINICAL TRIAL; CONTACTING SURFACES; DESIGN RATIONALE; DEVICE FAILURES; HEMOCOMPATIBILITY; LEFT VENTRICULAR ASSIST SYSTEMS; MODIFIED INDICES;

SHEAR FLOW;

HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD COMPATIBILITY; CANNULA; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; DEVICE COMPARISON; FLOW RATE; HEMOCOMPATIBILITY; HEMOLYSIS; IN VITRO STUDY; IN VIVO STUDY; LEFT VENTRICULAR ASSIST DEVICE; NONHUMAN; PRECLINICAL STUDY; PRIORITY JOURNAL; PUMP; SHEAR STRESS; SURFACE PROPERTY; THROMBOSIS; ANIMAL; BOVINE; EQUIPMENT DESIGN; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; HYDRODYNAMICS; MATERIALS TESTING; SHEAR STRENGTH;

ANIMALS; CATTLE; EQUIPMENT DESIGN; HEART FAILURE; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; HYDRODYNAMICS; MATERIALS TESTING; SHEAR STRENGTH;

EID: 84969730553     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000388     Document Type: Article

References (21)

1. Pagani FD, Miller LW, Russell SD, et al. HeartMate II Investigators: Extended mechanical circulatory support with a continuousflow rotary left ventricular assist device. J Am Coll Cardiol 54: 312-321, 2009
2. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-US food and drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (interagency registry for mechanically assisted circulatory support). J Am Coll Cardiol 57: 1890-1898, 2011
3. Slaughter MS, Rogers JG, Milano CA, et al. HeartMate II Investigators: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361: 2241-2251, 2009
4. Jorde UP, Kushwaha SS, Tatooles AJ, et al. HeartMate II Clinical Investigators: Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: A prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 63: 1751-1757, 2014
5. Starling RC, Blackstone EH, Smedira NG. Increase in left ventricular assist device thrombosis. N Engl J Med 370: 1465-1466, 2014
6. Arnold WS, Bourque K. The engineer and the clinician: Understanding the work output and troubleshooting of the HeartMate II rotary flow pump. J Thorac Cardiovasc Surg 145: 32-36, 2013
7. Cowger J, Rao V, Massey T, et al. Comprehensive review and suggested strategies for the detection and management of aortic insufficiency in patients with a continuous-flow left ventricular assist device. J Heart Lung Transplant 34: 149-157, 2015
8. Morgan JA, Brewer RJ, Nemeh HW, et al. Stroke while on longterm left ventricular assist device support: incidence, outcome, and predictors. ASAIO J 60: 284-289, 2014
9. Larose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J 56: 285-289, 2010
10. Saito S, Yamazaki K, Nishinaka T, et al. J-MACS Research Group: Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: A Japanese multicenter study using J-MACS. J Heart Lung Transplant 33: 599-608, 2014
11. Sakaguchi T, Matsumiya G, Yoshioka D, et al.: DuraHeart magnetically levitated left ventricular assist device. Circulation 77: 1736-1741, 2013
12. Farrar DJ, Bourque K, Dague CP, Cotter CJ, Poirier VL. Design features, developmental status, and experimental results with the Heartmate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO J 53: 310-315, 2007
13. G oubergrits L, Affeld K. Numerical estimation of blood damage in artificial organs. Artif Organs 28: 499-507, 2004
14. ASTM F1841-97. Standard practice for assessment of hemolysis in continuous flow blood pumps. ASTM Intl 2013
15. ASTM F1830-97. Standard practice for selection of blood for in vitro evaluation of blood pumps. ASTM Intl 2013
16. Bourque K, Gernes DB, Loree HM 2nd, et al. HeartMate III: Pump design for a centrifugal LVAD with a magnetically levitated rotor. ASAIO J 47: 401-405, 2001
17. Bourque K, Gernes DB, Loree HM, et al. Incorporation of electronics within a compact, fully implanted left ventricular assist device. Artif Organs 26: 939-942, 2002
18. Bourque K, Dague C, Farrar D, et al. In vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta. Artif Organs 30: 638-642, 2006
19. Tsai HM. Shear stress and von Willebrand factor in health and disease. Semin Thromb Hemost 29: 479-488, 2003
20. Slaughter MS, Sobieski MA 2nd, Graham JD, Pappas PS, Tatooles AJ, Koenig SC. Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device. Int J Artif Organs 34: 461-468, 2011
21. Schmitto JD, Hanke JS, Rojas SV, Avsar M, Haverich A. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant 34: 858-860, 2015